Recipharm Ups Inhalation Capacity with $60M Sanofi U.K. Plant Buy
Recipharm Ups Inhalation Capacity with $60M Sanofi U.K. Plant Buy
Attachment: farma
Recipharm has paid $60 million to acquire Sanofi's inhalation therapies contract manufacturing plant in Haverhill, U.K. The new site will complement the company's existing inhalation plant in Research Triangle Park (RTP), North Carolina. Industrial Info's Pharmaceutical & Biotech Business Intelligence Platform has detailed plant reports on 22 Recipharm facilities across the globe.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- ENGIE Deal Bolsters Big-Ticket Solar, Wind Projects Across U.S.
- EQT Corporation, U.S. Oil & Gas M&A Activity: Your Daily Energy News
- Romania Backs First Offshore Wind Bill
- From Farms to Forks: Exploring Meat Processing Investment Surge
- IEA Projects Another Record Year of Global Electric Vehicle Sales
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
